F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma.

[1]  Jin-Sook Ryu,et al.  Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET. , 2005, Oral oncology.

[2]  Q. Le,et al.  Positron‐Emission Tomography for Surveillance of Head and Neck Cancer , 2005, The Laryngoscope.

[3]  A. Hogg,et al.  Usefulness of fluorine‐18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck , 2004, Head & neck.

[4]  T. Yen,et al.  Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  H. Foehrenbach,et al.  Fdg-Pet Scan in Local Follow-up of Irradiated Head and Neck Squamous Cell Carcinomas , 2004, The Annals of otology, rhinology, and laryngology.

[6]  C. R. Leemans,et al.  Genetically Altered Fields as Origin of Locally Recurrent Head and Neck Cancer , 2004, Clinical Cancer Research.

[7]  Mithat Gonen,et al.  Diagnostic and Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma , 2002 .

[8]  R. D'Agostino,et al.  Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer , 2001, Head & neck.

[9]  P. V. van Rijk,et al.  F‐18‐fluoro‐deoxy‐glucose positron‐emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer , 2001, Head & neck.

[10]  M. Remacle,et al.  Positron Emission Tomography With Fluorodeoxyglucose for Suspected Head and Neck Tumor Recurrence in the Symptomatic Patient , 2000, The Laryngoscope.

[11]  B C Stack,et al.  Surveillance for recurrent head and neck cancer using positron emission tomography. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Alavi,et al.  Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2‐18f‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography , 1999, The Laryngoscope.

[13]  K. Geisinger,et al.  Pet scanning in head and neck oncology: A review , 1998, Head & neck.

[14]  J. Bourhis,et al.  Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks. , 1996, International journal of radiation oncology, biology, physics.

[15]  H. Minn,et al.  Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  G. V. von Schulthess,et al.  Positron emission tomography in the early follow-up of advanced head and neck cancer. , 2004, Archives of otolaryngology--head & neck surgery.

[17]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[18]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[19]  S. Manolidis,et al.  The use of positron emission tomography scanning in occult and recurrent head and neck cancer. , 1998, Acta oto-laryngologica. Supplementum.